Literature DB >> 29584619

PAI1 mediates fibroblast-mast cell interactions in skin fibrosis.

Neha Pincha1,2, Edries Yousaf Hajam1,3, Krithika Badarinath1,4, Surya Prakash Rao Batta1, Tafheem Masudi1, Rakesh Dey1, Peter Andreasen5, Toshiaki Kawakami6,7, Rekha Samuel8, Renu George9, Debashish Danda10, Paul Mazhuvanchary Jacob11, Colin Jamora1.   

Abstract

Fibrosis is a prevalent pathological condition arising from the chronic activation of fibroblasts. This activation results from the extensive intercellular crosstalk mediated by both soluble factors and direct cell-cell connections. Prominent among these are the interactions of fibroblasts with immune cells, in which the fibroblast-mast cell connection, although acknowledged, is relatively unexplored. We have used a Tg mouse model of skin fibrosis, based on expression of the transcription factor Snail in the epidermis, to probe the mechanisms regulating mast cell activity and the contribution of these cells to this pathology. We have discovered that Snail-expressing keratinocytes secrete plasminogen activator inhibitor type 1 (PAI1), which functions as a chemotactic factor to increase mast cell infiltration into the skin. Moreover, we have determined that PAI1 upregulates intercellular adhesion molecule type 1 (ICAM1) expression on dermal fibroblasts, rendering them competent to bind to mast cells. This heterotypic cell-cell adhesion, also observed in the skin fibrotic disorder scleroderma, culminates in the reciprocal activation of both mast cells and fibroblasts, leading to the cascade of events that promote fibrogenesis. Thus, we have identified roles for PAI1 in the multifactorial program of fibrogenesis that expand its functional repertoire beyond its canonical role in plasmin-dependent processes.

Entities:  

Keywords:  Cell Biology; Fibrosis; Inflammation; Innate immunity; Skin

Mesh:

Substances:

Year:  2018        PMID: 29584619      PMCID: PMC5919880          DOI: 10.1172/JCI99088

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  81 in total

1.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

2.  PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.

Authors:  T Oda; Y O Jung; H S Kim; X Cai; J M López-Guisa; Y Ikeda; A A Eddy
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

Review 3.  Mast cells and fibrosis. The relevance to scleroderma.

Authors:  H N Claman
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

4.  IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway.

Authors:  S Hashimoto; Y Gon; I Takeshita; S Maruoka; T Horie
Journal:  J Allergy Clin Immunol       Date:  2001-06       Impact factor: 10.793

Review 5.  Mast cell production and response to IL-4 and IL-13.

Authors:  Jamie J A McLeod; Bianca Baker; John J Ryan
Journal:  Cytokine       Date:  2015-06-15       Impact factor: 3.861

6.  Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors.

Authors:  Metin Artuc; U Muscha Steckelings; Beate M Henz
Journal:  J Invest Dermatol       Date:  2002-03       Impact factor: 8.551

Review 7.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

8.  Snail cooperates with KrasG12D to promote pancreatic fibrosis.

Authors:  Mario A Shields; Kazumi Ebine; Vaibhav Sahai; Krishan Kumar; Kulsumjehan Siddiqui; Rosa F Hwang; Paul J Grippo; Hidayatullah G Munshi
Journal:  Mol Cancer Res       Date:  2013-06-12       Impact factor: 5.852

9.  Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.

Authors:  Malgorzata Wygrecka; Bhola K Dahal; Djuro Kosanovic; Frank Petersen; Brigitte Taborski; Susanne von Gerlach; Miroslava Didiasova; Dariusz Zakrzewicz; Klaus T Preissner; Ralph T Schermuly; Philipp Markart
Journal:  Am J Pathol       Date:  2013-04-04       Impact factor: 4.307

10.  Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats.

Authors:  Shinobu Miyazawa; Osamu Hotta; Naoko Doi; Yumiko Natori; Kiyotaka Nishikawa; Yasuhiro Natori
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

View more
  17 in total

Review 1.  Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.

Authors:  Benjamin Korman
Journal:  Transl Res       Date:  2019-02-23       Impact factor: 7.012

2.  Activation of Fibroblast Contractility via Cell-Cell Interactions and Soluble Signals.

Authors:  Neha Pincha; Dyuti Saha; Tanay Bhatt; Ravindra K Zirmire; Colin Jamora
Journal:  Bio Protoc       Date:  2018-09-20

3.  Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host Disease.

Authors:  Ethan Strattan; Senthilnathan Palaniyandi; Reena Kumari; Jing Du; Natalya Hakim; Timothy Huang; Melissa V Kesler; C Darrell Jennings; Jamie L Sturgill; Gerhard C Hildebrandt
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

Review 4.  Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis.

Authors:  Chang-Youh Tsai; Song-Chou Hsieh; Tsai-Hung Wu; Ko-Jen Li; Chieh-Yu Shen; Hsien-Tzung Liao; Cheng-Han Wu; Yu-Min Kuo; Cheng-Shiun Lu; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

5.  Identification of molecular biomarkers associated with disease progression in the testis of bulls infected with Besnoitia besnoiti.

Authors:  David González-Barrio; Carlos Diezma-Díaz; Daniel Gutiérrez-Expósito; Enrique Tabanera; Alejandro Jiménez-Meléndez; Manuel Pizarro; Marta González-Huecas; Ignacio Ferre; Luis M Ortega-Mora; Gema Álvarez-García
Journal:  Vet Res       Date:  2021-07-22       Impact factor: 3.683

Review 6.  Finding Solutions for Fibrosis: Understanding the Innate Mechanisms Used by Super-Regenerator Vertebrates to Combat Scarring.

Authors:  Fallon Durant; Jessica L Whited
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

Review 7.  Unraveling SSc Pathophysiology; The Myofibroblast.

Authors:  Arjan van Caam; Madelon Vonk; Frank van den Hoogen; Peter van Lent; Peter van der Kraan
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

Review 8.  Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances.

Authors:  Paoline Laurent; Vanja Sisirak; Estibaliz Lazaro; Christophe Richez; Pierre Duffau; Patrick Blanco; Marie-Elise Truchetet; Cécile Contin-Bordes
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561

Review 9.  Diet and Skin Aging-From the Perspective of Food Nutrition.

Authors:  Changwei Cao; Zhichao Xiao; Yinglong Wu; Changrong Ge
Journal:  Nutrients       Date:  2020-03-24       Impact factor: 5.717

Review 10.  Scars or Regeneration?-Dermal Fibroblasts as Drivers of Diverse Skin Wound Responses.

Authors:  Dongsheng Jiang; Yuval Rinkevich
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.